Samuel S. Lentz
AuthID: R-00K-BP5
1
TITLE: Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma: A gynecologic oncology group study. A Gynecologic Oncology Group study Full Text
AUTHORS: David Scott Miller ; John A Blessing; Samuel S Lentz; Scott McMeekin D.; Denise Mackey;
PUBLISHED: 2003, SOURCE: Cancer, VOLUME: 98, ISSUE: 8
AUTHORS: David Scott Miller ; John A Blessing; Samuel S Lentz; Scott McMeekin D.; Denise Mackey;
PUBLISHED: 2003, SOURCE: Cancer, VOLUME: 98, ISSUE: 8
2
TITLE: A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: A gynecologic oncology group study Full Text
AUTHORS: David Scott Miller ; John A Blessing; Samuel S Lentz; Steven E Waggoner; Denise Mackey;
PUBLISHED: 2002, SOURCE: Gynecologic Oncology, VOLUME: 87, ISSUE: 3
AUTHORS: David Scott Miller ; John A Blessing; Samuel S Lentz; Steven E Waggoner; Denise Mackey;
PUBLISHED: 2002, SOURCE: Gynecologic Oncology, VOLUME: 87, ISSUE: 3
